Viropro Obtains $500,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    2151 O’Toole Ave. San Jose, CA 95131 USA
  • Company Description
    Viropro is an integrated developer and manufacturer of biopharmaceutical products that address unmet medical need in an efficient and cost-effective way.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The proceeds will be used for the preparation of audited financial statements, the implementation of the company’s strategic plans and for general corporate purposes.
  • M&A Terms
  • Venture Investor